Using transgenic mouse models, we observed that SLC16A1 and SLC16A3 were both over‐expressed from normal mouse prostate to PIN lesions and medium and advanced PTEN‐null tumours (Figure7A, B). The gene discussed is PTEN; the disease is neoplasm.